Maintenance Notice (8:45 AM - 1:00 PM February 22, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | New tool "TCI SpectraViewer" | [Product Highlights] Chemiluminescent Reagents for... | Product Document Searching Made Easy by 2D Code!
Maximum quantity allowed is 999
Please select the quantity
Cancer Research
Tumor-associated AntigensAn Antibiotic Substance in Cordyceps sinensis CordycepinAntimicrobials and Antitumors for Research and Experimental UseCurcumin Analogues with Enhanced Antitumor ActivitiesAntitumor Molecular-Targeted AgentsCeramide Transport Protein (CERT) Inhibitor HPA-12Rapid Apoptosis-Inducer: RaptinalNon-Receptor Tyrosine Kinase (Non-RTK) InhibitorsCrude Medicine Ingredients for Cancer ResearchUbiquitin-Proteasome System (UPS) Research ReagentsExplore Cancer Research Categories
Androgen Receptor (AR) Inhibitors
CXCR Inhibitors
Crude Medicine Ingredients for Cancer Research
Cytochrome P450 (CYP) Inhibitors
DNA Modification / Repair [Antitumor Agents for Research]
DNA Synthesis Inhibitors [Antitumor Agents for Research]
DNA-RNA Transcription Regulators [Antitumor Agents for Research]
Enzyme Inhibitors and Activators [Antitumor Agents for Research]
Gene Regulation [Antitumor Agents for Research]
HSP-90 Inhibitors
Hedgehog Signaling Pathway Inhibitors (Antagonists)
Hypoxia-inducible factor (HIF) Inhibitors
Microtubule Inhibitors
Mitotic Inhibitors
Poly(ADP-ribose) Polymerase (PARP) Inhibitors and Poly(ADP-ribose) Glycohydrolase (PARG) Inhibitors [Antitumor Agents for Research]
Telomerase Inhibitors
Therapy Adjuncts [Antitumor Agents for Research]
Topoisomerase Inhibitors
Tyrosine Kinase Inhibitors [Antitumor Agents]
p53 Inhibitors